Wagner S. Brum

Universidade Federal do Rio Grande do Sul — Brazil

Medicine · Health Sciences

30h-index4.2kcitations139works20.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(101), Dementia and Cognitive Impairment Research(96), Functional Brain Connectivity Studies(10), Bioinformatics and Genomic Networks(9), Cancer-related cognitive impairment studies(9)

Publications138 total

Reader Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test
Neurology·2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
Nature Medicine·2026· 3 citedOpen Access
Plasma <i>p</i> ‐tau changes across the clinical spectrum of Alzheimer's disease: a systematic review and meta‐analysis
Alzheimer s & Dementia·2025Open Access
Microglia as a key player in Aβ‐related astrocyte reactivity
Alzheimer s & Dementia·2025Open Access
Population enrichment strategy using <i>APOE</i> ε4 genotype in tau‐targeting trials for preclinical Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Imaging‐based biological staging associates with brain atrophy in preclinical Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Inflammation‐related proteomic changes in response to amyloid and tau pathologies
Alzheimer s & Dementia·2025Open Access
Prognostic utility of <i>p</i> ‐tau217 and tau PET in Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment
JAMA Neurology·2025· 1 citedOpen Access
Imaging‐based Biological Staging for Alzheimer's Disease Prognosis
Alzheimer s & Dementia·2025Open Access
Study Design of Draw‐10: a weekly blood draw study to understand the biological fluctuations of plasma pTau‐217
Alzheimer s & Dementia·2025Open Access
<i>APOE</i> ε4 genotyping for populational enrichment of tau‐targeting clinical trials in cognitively impaired individuals
Alzheimer s & Dementia·2025Open Access
Inflammation‐related proteomic changes in response to amyloid and tau pathologies
Alzheimer s & Dementia·2025Open Access
A protein panel including pTau217 outperforms pTau217 alone in identifying high tau load in amyloid positive individuals
Alzheimer s & Dementia·2025Open Access
The DROP‐AD project: AD biomarkers from dry blood spots
Alzheimer s & Dementia·2025Open Access
Alzheimer's Disease Plasma Biomarkers Performance in Brazilian Individuals
Alzheimer s & Dementia·2025Open Access
Biomarker‐Driven Patterns of Hippocampal Subfield Atrophy in Amnestic Mild Cognitive Impairment
Alzheimer s & Dementia·2025Open Access
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease
Nature Neuroscience·2025· 5 citedOpen Access
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study
Acta Neuropathologica·2025· 1 citedOpen Access
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease
JAMA Neurology·2025· 10 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Kaj Blennow(41), Nicholas J. Ashton(36), Henrik Zetterberg(33), Pedro Rosa‐Neto(28), Andréa Lessa Benedet(24), Tharick A. Pascoal(22), Joseph Therriault(21), Thomas K. Karikari(21), Eduardo R. Zimmer(18), Nesrine Rahmouni(16), Cécile Tissot(16), Oskar Hansson(16), Juan Lantero‐Rodriguez(15), Jenna Stevenson(15), Laia Montoliu‐Gaya(13), Erik Stomrud(10), Sebastian Palmqvist(9), João Pedro Ferrari‐Souza(9), Bruna Bellaver(9), Arthur C. Macedo(8)